SCHEMBL27535554

SCHEMBL27535554

Cc1cc([N+](=O)[O-])c(OC(=O)NC(C)(C)C)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TBXA2R P21731 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.38
PPIA P62937 1/20 0.38
LMNA P02545 4/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 2/20 0.37
THRB P10828 1/20 0.37
NPSR1 Q6W5P4 2/20 0.37
MAPT P10636 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27566023 0.85 POLB (0.40) TBXA2RLMNAPOLBALDH1A1THRB
SCHEMBL27499149 0.85 LMNA (0.38) TBXA2RLMNAPOLBALDH1A1THRB
SCHEMBL27539107 0.83 LMNA (0.41) MEN1KMT2ATBXA2RLMNAPOLB
SCHEMBL28742591 0.82 HCAR3 (0.38) MEN1KMT2ATBXA2RL3MBTL1LMNA
SCHEMBL27641481 0.82 AR (0.41) TBXA2RLMNASMN1; SMN2ALDH1A1MAPT
SCHEMBL27500364 0.81 ALDH1A1 (0.37) NPC1RAB9ATBXA2RL3MBTL1LMNA
SCHEMBL27539464 0.81 ALDH1A1 (0.41) MEN1KMT2ATBXA2RL3MBTL1LMNA
SCHEMBL27485408 0.80 MAPT (0.42) MEN1KMT2ATBXA2RLMNAPOLB
SCHEMBL27472206 0.80 LMNA (0.49) NPC1RAB9AMEN1KMT2ATBXA2R
SCHEMBL27539111 0.79 AR (0.41) TBXA2RLMNASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1856312-A Combination of mGluR2 antagonist and AChE inhibitor for treatment of acute and/or chronic neurological disorders HOFFMANN LA ROCHE (CH) 2006-11-01 CN disclosed
CN-1264825-C Dihydro-benzo [ b ] [1,4] diazepin * -2-one derivatives as mGluR2 antagonists II HOFFMANN LA ROCHE (CH) 2006-07-19 CN disclosed
CN-1535266-A Dihydro-benzo [b][1,4] diazepin-2-one derivatives as mglur 2 antagonists II - 2004-10-06 CN disclosed